ArcticDX: A genetic test for macular degeneration

 

Age Related Macular Degeneration is the leading cause of legal blindness in the Western world. Would you want to know if you were at risk of developing the disease?

MaRS client ArcticDX has developed a genetic test for macular degeneration—and is in the trial phase for a similar genetic test for colon cancer. ArcticDX’s tests can specifically identify if a person has an increased risk of developing a disease based on their genes. Jim Pelot, ArcticDX’s CFO, describes the tests, discusses the challenges and opportunities of the diagnostic space in Canada and explains the benefits of working with MaRS.

In Meet the Entrepreneurs

 
 
Get More From MaRS   MaRS NEWSLETTERS
Facebook Twitter Vimeo Flickr

MaRS Charitable Registration Number
876682717 RR0001

Please enter your email address to subscribe to our newsletter